Revolution Medicines (RVMDW) Intangibles (2019 - 2026)

Revolution Medicines' Intangibles history runs 8 years deep, the most recent figure standing at $55.8 million for Q1 2026.

• In Q1 2026, Intangibles fell 11.82% year-over-year to $55.8 million; the TTM figure through Mar 2026 stood at $55.8 million (down 11.82% YoY), while the FY2025 annual figure was $55.8 million, down 1.54% from the prior year.
• Intangibles for Q1 2026 stood at $55.8 million, roughly flat from $55.8 million in the prior quarter.
• The five-year high for Intangibles was $63.3 million in Q1 2022, with the low at $55.8 million in Q1 2023.
• The 5-year median for Intangibles is $57.7 million (2023), against an average of $58.3 million.
• The sharpest annual moves came in 2023 and 2025: Intangibles dropped 11.82% in 2023, then rose 11.14% in 2025.
• Revolution Medicines' Intangibles stood at $58.8 million in 2022, then decreased by 1.82% to $57.7 million in 2023, then fell by 1.85% to $56.7 million in 2024, then decreased by 1.54% to $55.8 million in 2025, then changed by 0.0% to $55.8 million in 2026.
• Business Quant data shows RVMDW's Intangibles at $55.8 million in Q1 2026, $55.8 million in Q4 2025, and $63.3 million in Q3 2025.